The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study)

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

April 30, 2017

Conditions
Foot Ulcer, Diabetic
Interventions
DEVICE

Sorbact®

Sorbact® is available in many types and sizes. These different presentations are available allowing management of quite all types of wounds of various anatomical locations, sizes or depths. Application of any of these presentations is allowed and may change during study course according to wound evolution.

DEVICE

Best local cares

Participating centers will provide a list of dressings they planned to use in the best local cares arm. This list must be validated by the study Steering Committee members

Trial Locations (15)

33401

Maison de santé protestante de Bordeaux Bagatelle, Talence

34295

CHRU Lapeyronie, Montpellier

59037

CHRU LILLE Hôpital Claude Huriez, Lille

67000

Hopital Civil, Strasbourg

69677

Hôpital Cardio-vasculaire Louis Pradel, Bron

656 91

Faculty of Medicine MU a FH St. Ann Brno, Brno

703 00

Cardiologic and pediatric ambulance s.r.o., Ostrava-vitkovice

140 21

Institute for Clinical and Experimental Medicine, Prague

169 02

Podiatrie - Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha, Prague

180 81

Bulovka Hospital, Prague

80-952

Gdański Uniwersytet Medyczny, Gdansk

20-090

Instytut Medycny Wsi, Lublin

61-541

Angiodiabetica, Poznan

02-097

Warszawski Uniwersytet Medyczny, Warsaw

02-541

PODOS, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

RCTs

INDUSTRY

lead

INRESA Pharma

INDUSTRY

NCT02334241 - The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study) | Biotech Hunter | Biotech Hunter